You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hürthle Cell Carcinoma and Follicular Thyroid Carcinoma

Completed
  • Huerthle Cell Carcinoma
    • (no location specified)
    Jul 20, 2023

    Nasopharyngeal Carcinoma Trial in Wuhan (KSD-101)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • KSD-101
    • Wuhan, China
      Tongji Hospital, Tongji Medical College, Huazhong University of
    Oct 19, 2023

    Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy

    Recruiting
    • Squamous Cell Carcinoma of Oral Cavity
    • +3 more
    • Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
    • Gliwice, Silesia, Poland
      The Maria Sklodowska-Curie National Research Institute of Oncolo
    Aug 7, 2023

    Delving Into Participation Trends in Renal Cell Carcinoma

    Not yet recruiting
    • Renal Cell Carcinoma
      • San Francisco, California
        Power Life Sciences
      Oct 16, 2023

      Hepatocellular Carcinoma Trial in Seoul (Lenvatinib)

      Recruiting
      • Hepatocellular Carcinoma
      • Seoul, Korea, Republic of
        Asan Medical Center
      Nov 14, 2023

      Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with

      Not yet recruiting
      • Advanced Esophageal Squamous Carcinoma With Oligometastases
      • simultaneous with radiotherapy
      • synchronous with radiotherapy
      • (no location specified)
      Nov 16, 2023

      Merkel Cell Carcinoma Clinical Trial Engagement Patterns

      Not yet recruiting
      • Merkel Cell Carcinoma
        • San Francisco, California
          Power Life Sciences
        Sep 8, 2023

        Nasopharyngeal Carcinoma Trial in Hangzhou (Endostar and Envafolimab)

        Recruiting
        • Nasopharyngeal Carcinoma
        • Endostar and Envafolimab
        • Hangzhou, Zhejiang, China
          Zhejiang Cancer Hospital
        Sep 24, 2023

        Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Nov 30, 2023

        Immunotherapy in Upper Tract Urothelial Carcinoma

        Not yet recruiting
        • Urothelial Carcinoma
        • Evaluation of anti-PD-(L)1 immunotherapy efficacy
        • (no location specified)
        Oct 27, 2023

        Advanced Hepatocellular Carcinoma Trial (CD-801)

        Not yet recruiting
        • Advanced Hepatocellular Carcinoma
        • (no location specified)
        Oct 13, 2023

        Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin Trial in Marlborough (PH-762)

        Not yet recruiting
        • Squamous Cell Carcinoma of the Skin
        • +2 more
        • Marlborough, Massachusetts
          Phio Pharmaceuticals Corp.
        Aug 25, 2023

        Liver Carcinoma, Hepatic Cell Carcinoma Trial in Wuhan (CAR-GPC3 T cells)

        Recruiting
        • Liver Carcinoma
        • Hepatic Cell Carcinoma
        • CAR-GPC3 T cells
        • Wuhan, Hubei, China
          Tao Zhang
        Nov 20, 2023

        Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

        Recruiting
        • Metastatic Esophageal Squamous Cell Carcinoma
        • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
        • Qingdao, Shandong, China
        • +1 more
        Nov 13, 2023

        Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

        Not yet recruiting
        • Pancreatic Adenocarcinoma
        • +6 more
        • (no location specified)
        Aug 4, 2023

        Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

        Recruiting
        • Esophageal Squamous Cell Carcinoma
        • Head and Neck Squamous Cell Carcinoma
        • Chengdu, Sichuan, China
          West China Hospital, Sichuan University
        Oct 25, 2023

        Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

        Recruiting
        • Esophageal Squamous Cell Carcinoma
          • Shijiazhuang, Hebei, China
            Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
          Oct 25, 2023

          Resectable Hepatocellular Carcinoma Trial in Jakarta Pusat (Liver Resection)

          Completed
          • Resectable Hepatocellular Carcinoma
          • Liver Resection
          • Jakarta Pusat, DKI Jakarta, Indonesia
            Dr. Cipto Mangunkusumo General Hospital
          Aug 24, 2023

          Pure Florid and Pleomorphic Lobular Carcinoma in Situ of Breast:

          Recruiting
          • Pleomorphic Lobular Breast Carcinoma in Situ
          • Breast Florid Lobular Carcinoma in Situ
          • Surgical wide local excision
          • +4 more
          • Padova, Italy
            Istituto Oncologico Veneto IRCCS
          Nov 14, 2023

          Merkel Cell Carcinoma Trial in Wollstonecraft (Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination)

          Not yet recruiting
          • Merkel Cell Carcinoma
          • Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination
          • Wollstonecraft, New South Wales, Australia
            Melanoma Institute Australia
          Nov 21, 2023

          Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

          Not yet recruiting
          • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
          • Guangzhou, Guangdong, China
            Sun Yat-sen University
          Oct 24, 2023

          Cell Carcinoma Trial in Nice (Tirbanibulin)

          Not yet recruiting
          • Cell Carcinoma
          • Nice, Alpes-maritimes, France
            CHU de Nice - Hôpital de l'Archet
          Oct 27, 2023

          Hepatocellular Carcinoma Trial in Wuhan (Sintilimab, Transarterial Chemoembolization (TACE))

          Not yet recruiting
          • Hepatocellular Carcinoma
          • Sintilimab
          • Transarterial Chemoembolization (TACE)
          • Wuhan, Hubei, China
            Tongji Hospital, Tongji Medical College, Huazhong University of
          Oct 17, 2023

          Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity

          Not yet recruiting
          • Nasopharyngeal Carcinoma
            • Fuzhou, Fujian, China
              Department of radiation oncology, Fujian cancer hospital
            Nov 16, 2023

            Nasopharyngeal Carcinoma by AJCC V8 Stage Trial (New-mode reduce-volume target IMRT)

            Not yet recruiting
            • Nasopharyngeal Carcinoma by AJCC V8 Stage
            • New-mode reduce-volume target IMRT
            • (no location specified)
            Oct 18, 2023